SARS-CoV-2 immune response
Latest Information Update: 12 May 2021
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 12 May 2021 New trial record